or Try an Advanced Search...

    ETF Components for BCIL - Bancreek International Large Cap ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ABBV A -0.16 3.51

    Represented by ETF Holdings

    Keywords: Adalimumab Advanced Prostate Cancer Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Hypothyroidism Immunosuppressants Infection
    Industries: Drug Manufacturers - Major

    Recent News for Bancreek International Large Cap ETF & its Holdings

    Date Stock Title
    Nov 1 ABBV Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
    Nov 1 ABBV Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
    Nov 1 ABBV AbbVie Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 1 ABBV AbbVie and EvolveImmune Therapeutics sign oncology collaboration
    Nov 1 ABBV 5 Stocks That Recently Announced Dividend Hikes
    Nov 1 ABBV Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
    Nov 1 ABBV Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
    Oct 31 ABBV AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
    Oct 31 ABBV AbbVie announces 2025 dividend increase of 5.8% to $1.64 from $1.55 per share
    Oct 31 ABBV 5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
    Oct 31 ABBV AbbVie Inc (ABBV) Q3 2024 Earnings Call Highlights: Strong Growth in Ex-Humira Platform and ...
    Oct 31 ABBV Q3 2024 AbbVie Inc Earnings Call
    Oct 30 ABBV AbbVie: 3 Positives From The Earnings Report
    Oct 30 ABBV AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
    Oct 30 ABBV AbbVie Inc. (ABBV) Q3 2024 Earnings Call Transcript
    Oct 30 ABBV What’s behind AbbVie's Q3 revenue beat?
    Oct 30 ABBV AbbVie (ABBV) Q3 2024 Earnings Call Transcript
    Oct 30 ABBV AbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View
    Oct 30 ABBV Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics
    Oct 30 ABBV AbbVie Raises Full-Year Outlook Following Third-Quarter Beat
    BCIL pursues long-term growth by investing in large-capitalization companies in developed markets outside the United States, spreading investments across a minimum of three countries. The fund utilizes a proprietary research method to identify firms it considers having strong business models. This decision-making process focuses on the capacity of investments to grow capital over time, taking into account specific company information, and fundamental and economic indicators. BCIL aims to maintain a diversified portfolio of 25 to 50 securities, reconstituted and rebalanced monthly, with a strategy to keep investments for more than a year. A 10% cap is placed on any single security in the portfolio. Additionally, BCIL may include investments in similar ETFs or investment companies and has the capability to hedge against currency risks in non-US markets under specific conditions.
    International Finance Corporation
    Back to the Main BCIL Page...